Phenex AG develops novel indications for FXR-targeted drugs and wins Prof. Dr. Michael Trauner as…
PhenexJuly 2, 2009
Biogen Idec uses Phenex´ expertise to identify novel ligands for an undisclosed nuclear receptor Ludwigshafen,…
PhenexDecember 3, 2008
A Syndicate of institutional and private investors provides funding for the development of Phenex´ drug…
PhenexOctober 2, 2008
Phenex uses its Nuclear Receptor assay battery and its SNuRM® platform to analyze compounds from…
PhenexMay 9, 2007
Phenex AG provides compound profiling services to BayerSchering Pharma AG Ludwigshafen, Germany, February 8th, 2007…
PhenexFebruary 8, 2007
The nuclear receptor-based drug discovery company starts to build a broad patent estate on FXR-…
PhenexMarch 8, 2006
equinet Venture Partners and KfW become shareholders in Phenex; additional funding comes from BioChance plus…
PhenexOctober 11, 2005
The Nuclear Receptor Research Company strengthens its service business while heading for a funding round…
PhenexJuly 28, 2005
PheneX provides a copy of its comprehensive Nuclear Receptor Research tool and clone collection to…
PhenexMay 14, 2004
